Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

Item
http://www.wikidata.org/entity/Q35610251
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsRisk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threatHepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis.Infection risk associated with anti-TNF-α agents: a review.Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): a Systematic Review and Meta-analysis.Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.Prevention of HBV reactivation in patients treated with biologic agents.Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study.Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.
P2860

Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

Item
http://www.wikidata.org/entity/Q35610251
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@ast
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@en
type
label
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@ast
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@en
prefLabel
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@ast
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Past hepatitis B virus infecti ...... -modifying antirheumatic drugs
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932